Malaria vaccine - Artificial Cell TechnologiesAlternative Names: Synthetic nanocapsule malaria vaccine - Artificial Cell Technologies (ACT)
Latest Information Update: 30 Oct 2013
At a glance
- Originator Artificial Cell Technologies
- Class Parasitic vaccines; Peptide vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Malaria
Most Recent Events
- 30 Oct 2013 Preclinical trials in Malaria (prevention) in USA (unspecified route) before Oct 2013